\begin{lstlisting}[language=json,numbers=none]
Reformat Answer:

**Key Milestones in the Development of HMG-CoA Reductase Inhibitors**
1. **1971**: Japanese scientists initiate research into inhibitors of HMG-CoA reductase.
2. **Mid-1970s**: Lovastatin (mevinolin) is isolated from a mold and identified as the first clinically useful compound.
3. **1980s**: Lovastatin is used to treat more severe forms of hypercholesterolemia.
4. **Landmark trials**: Simvastatin demonstrates its potential for cardio-prevention.
5. **2001**: Cerivastatin is withdrawn from the market due to a higher incidence of rhabdomyolysis.

Scores:
SkyworkLlama:-30.1250
SkyworkGemma:-9.3125
URM:-2.8281
QRM:0.8603
Internlm2:1.2460
\end{lstlisting}